Detroit cancer center installs GE’s molecular breast imaging system

The Barbara Ann Karmanos Cancer Center in Detroit has installed GE Healthcare’s Discovery NM750b molecular breast imaging (MBI) device.

MBI uses radiotracers to locate potential tumors, and can reduce the number of false positives for women with dense breast tissue compared with standard mammography, according to GE.

The Discovery NM750b uses solid-state Cadmium Zinc Telluride (CZT) dual detectors and patients can sit or stand during the scan. The system was first launched globally in 2011.